Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1167/IOVS.06-1249PMID 17962460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma.

  2006cited by this paper
• Glaucoma: ocular Alzheimer's disease?

  2003cited by this paper
• High Occurrence Rate of Glaucoma among Patients with Alzheimer’s Disease

  2002cited by this paper
• Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

  2002cited by this paper
• Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.

  2002cited by this paper
• Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.

  2001cited by this paper
• Number of Aβ Inoculations in APP+PS1 Transgenic Mice Influences Antibody Titers, Microglial Activation, and Congophilic Plaque Levels

  2001cited by this paper
• Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease.

  2001cited by this paper
• Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease

  2001cited by this paper
• Alzheimer's peptide: a possible link between glaucoma, exfoliation syndrome and Alzheimer's disease.

  2001cited by this paper
• β-Amyloid-induced activation of Caspase-3 in primary cultures of rat neurons

  2000cited by this paper
• Immunohistochemical Analysis of Amyloid β-Protein Isoforms in CAA

  2000cited by this paper
• Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain

  2000cited by this paper
• Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

  2000cited by this paper
• Cerebral Amyloid Angiopathy in Alzheimer’s Disease and Related Disorders

  2000cited by this paper
• Chemical Analysis of Amyloid β Protein in CAA

  2000cited by this paper
• Neuropathologic Features and Grading of Alzheimer-Related and Sporadic CAA

  2000cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper
• Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation

  1999cited by this paper
• Proteolytic Processing of the Alzheimer’s Disease Amyloid Precursor Protein within Its Cytoplasmic Domain by Caspase-like Proteases*

  1999cited by this paper
• Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation.

  1999cited by this paper
• Activation of Neuronal Caspase-3 by Intracellular Accumulation of Wild-Type Alzheimer Amyloid Precursor Protein

  1999cited by this paper
• Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein.

  1999cited by this paper
• Novel Domain-Specific Actions of Amyloid Precursor Protein on Developing Synapses

  1998cited by this paper
• Increased Production of Amyloid Precursor Protein Provides a Substrate for Caspase-3 in Dying Motoneurons

  1998cited by this paper
• Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice.

  1998cited by this paper
• Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

  1997cited by this paper
• The cellular mechanism underlying neuronal degeneration in glaucoma: parallels with Alzheimer's disease.

  1997cited by this paper
• Mechanisms of synaptic dysfunction in Alzheimer's disease.

  1995cited by this paper
• Differential vulnerability of neurochemically identified subpopulations of retinal neurons in a monkey model of glaucoma.

  1995cited by this paper
• Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease.

  1994cited by this paper
• High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy.

  1994cited by this paper
• The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis.

  1994cited by this paper
• Amyloid Precursor Protein Is Synthesized by Retinal Ganglion Cells, Rapidly Transported to the Optic Nerve Plasma Membrane and Nerve Terminals, and Metabolized

  1993cited by this paper
• The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

  1993cited by this paper
• The C‐Terminus of the β Protein is Critical in Amyloidogenesis a

  1993cited by this paper
• The C-terminus of the beta protein is critical in amyloidogenesis.

  1993cited by this paper
• Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease.

  1992cited by this paper
• The neurofilament triplet is present in distinct subpopulations of neurons in the central nervous system of the guinea-pig.

  1992cited by this paper
• A neurofilament protein antibody selectively labels a large ganglion cell type in the human retina.

  1992cited by this paper
• Beta amyloid precursor protein mediates neuronal cell‐cell and cell‐surface adhesion

  1991cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper
• Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

  1984cited by this paper
• Evidence for an amacrine cell system in the ganglion cell layer of the rat retina.

  1981cited by this paper

• Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies

  2024cites this paper
• Neuroprotection and glaucoma: current knowledge and future perspectives

  2024cites this paper
• Normal-Tension Glaucoma and Potential Clinical Links to Alzheimer’s Disease

  2024cites this paper
• The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach

  2024cites this paper
• A systematic proteomic profiling and pathway analysis of protein biomarkers in diabetic retinopathy with subsequent validation of the IL-6 upstream regulator

  2023cites this paper
• Potential role of Lycium barbarum polysaccharides in glaucoma management: evidence from preclinical in vivo studies

  2023cites this paper
• Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle?

  2023cites this paper
• Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance

  2022cites this paper
• The Small Molecule GAL-201 Efficiently Detoxifies Soluble Amyloid β Oligomers: New Approach towards Oral Disease-Modifying Treatment of Alzheimer’s Disease

  2022cites this paper
• Retinal Dysfunction in Alzheimer’s Disease and Implications for Biomarkers

  2021cites this paper
• Diet-Induced Obesity Disrupts Trace Element Homeostasis and Gene Expression in the Olfactory Bulb

  2020cites this paper
• Retinal biomarkers for Alzheimer’s disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis

  2020cites this paper
• Alterations in proteome of human sclera associated with primary open-angle glaucoma involve proteins participating in regulation of the extracellular matrix

  2020cites this paper
• Retinal ganglion cell loss and gliosis in the retinofugal projection following intravitreal exposure to amyloid-beta.

  2020cites this paper
• The Ocular Glymphatic Clearance System

  2019cites this paper
• [Selective α2 agonists in the treatment of glaucoma: neuroprotective properties and impact on ocular blood flow].

  2019cites this paper
• Primary open-angle glaucoma: on the development of novel therapeutic approaches

  2018cites this paper
• Neuro-pathological Implications of β-Amyloid Protein: An Update

  2018cites this paper
• Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease

  2018cites this paper
• Changes in ganglioside GM1 expression in glaucomic retina

  2018cites this paper
• Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma

  2018cites this paper
• Annexins in Glaucoma

  2018cites this paper
• Reduced Cerebrospinal Fluid Inflow to the Optic Nerve in Glaucoma.

  2018cites this paper
• The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma

  2017cites this paper
• Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer’s disease

  2017cites this paper
• Evidence for Cerebrospinal Fluid Entry Into the Optic Nerve via a Glymphatic Pathway.

  2017cites this paper
• Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma

  2017cites this paper
• Instructions for use Title VAV 2 and VAV 3 as Candidate Disease Genes for SpontaneousGlaucoma in Mice and Humans

  2017cites this paper
• Instructions for use Title VAV 2 and VAV 3 as Candidate Disease Genes for Spontaneous Glaucoma in Mice and Humans

  2017cites this paper
• Title At the interface of sensory and motor dysfunctions and Alzheimer ' s disease Permalink

  2017cites this paper
• Le rôle de la protéine tau dans la mort des cellules ganglionnaires de la rétine : cas du glaucome et de la maladie d’Alzheimer

  2017cites this paper
• Development of drug delivery system using albumin nanoparticles for sustained intraocular release of brimonidine

  2017cites this paper
• Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma

  2016cites this paper
• Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection

  2016cites this paper
• One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina

  2016cites this paper
• At the interface of sensory and motor dysfunctions and Alzheimer's disease

  2015cites this paper
• MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD).

  2015cites this paper
• Pharmacotherapy of Glaucoma

  2015cites this paper
• MicroRNA target prediction in glaucoma.

  2015cites this paper
• Differential roles of Aβ processing in hypoxia-induced axonal damage.

  2015cites this paper
• Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier

  2015cites this paper
• The current research status of normal tension glaucoma

  2014cites this paper
• Glaucoma and Alzheimer's disease: Their clinical similarity and future therapeutic strategies for glaucoma

  2014cites this paper
• Effect of the Aβ Aggregation Modulator MRZ-99030 on Retinal Damage in an Animal Model of Glaucoma

  2014cites this paper
• BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma.

  2014cites this paper
• Neuroprotection in glaucoma: present and future.

  2013cites this paper
• Progressive Neurodegeneration of Retina in Alzheimer’s Disease — Are β-Amyloid Peptide and Tau New Pathological Factors in Glaucoma?

  2013cites this paper
• The retina as a window to the brain—from eye research to CNS disorders

  2013cites this paper
• Glaucoma A Multifactorial Disease and Its Multidimensional Management

  2013cites this paper
• Glaucoma: An Extension of Various Chronic Neurodegenerative Disorders

  2013cites this paper
• Axonal protection via modulation of the amyloidogenic pathway in tumor necrosis factor-induced optic neuropathy.

  2012cites this paper
• The role of amyloid-β in retinal degeneration.

  2012cites this paper
• Loss of thioredoxin function in retinas of mice overexpressing amyloid β.

  2012cites this paper
• Amyloid Precursor Protein Is Required for Normal Function of the Rod and Cone Pathways in the Mouse Retina

  2012cites this paper
• An investigation into pro-apoptotic targets in experimental glaucoma and the neuroprotective effects of Ginkgo biloba in retinal ganglion cells

  2012cites this paper
• Protection of Retinal Ganglion Cells and Retinal Vasculature by Lycium Barbarum Polysaccharides in a Mouse Model of Acute Ocular Hypertension

  2012cites this paper
• Induction of amyloid-β1-42 in the retina and optic nerve head of chronic ocular hypertensive monkeys

  2012cites this paper
• An AD-Related Neuroprotector Rescues Transformed Rat Retinal Ganglion Cells from CoCl2-Induced Apoptosis

  2012cites this paper
• Auditory and visual temporal processing disruption in open angle glaucoma.

  2012cites this paper
• Estudo da eletrorretinografia do camundongo modelo de alzheimer (3xTg-AD)

  2011cites this paper
• Temporal processing in auditory and visual systems: evidence of wider central nervous system involvement in glaucoma

  2011cites this paper
• Development and Expression of Amyloid‐β Peptide 42 in Retinal Ganglion Cells in Rats

  2011cites this paper
• Glaucoma and Alzheimer's disease in the elderly

  2011cites this paper
• Retinal Disturbances in Patients and Animal Models with Huntington’s, Parkinson’s and Alzheimer’s Disease

  2011cites this paper
• Neuroprotection in glaucoma - Is there a future role?

  2010cites this paper
• VAV2 and VAV3 as Candidate Disease Genes for Spontaneous Glaucoma in Mice and Humans

  2010cites this paper
• Spatiotemporal characterization of optic nerve degeneration after chronic hypoperfusion in the rat.

  2010cites this paper
• Alzheimer's disease and retinal neurodegeneration.

  2009cites this paper
• Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease

  2009cites this paper
• [Current therapeutic approaches and involvement of amyloid-beta in retinal diseases].

  2009cites this paper
• Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection.

  2008cites this paper
• Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease.

  2008cites this paper
• Assessment of neuroprotection in the retina with DARC

  2008cites this paper
• Distribution of Amyloid Precursor Protein and Amyloid-β in Ocular Hypertensive C57BL/6 Mouse Eyes

  2005cites this paper